Raymond James & Associates’s The Beachbody Company, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 BODY.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding BODY.WS
Raymond James & Associates's BODY.WS Position: Q4 2023 in Review
Raymond James & Associates sold out of The Beachbody Company, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 (BODY.WS) in Q4 2023, closing a stake of 11,199 shares — an estimated $213 sold.
Raymond James & Associates first reported a position in BODY.WS in Q2 2021 and held it in 10 quarters. The position peaked at $94K in Q2 2021. 2 funds tracked by Wall St. Rank hold BODY.WS as of Q4 2023.
- Raymond James & Associates reported no remaining The Beachbody Company, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position as of Q4 2023 after selling out during the quarter.
- Raymond James & Associates sold 11,199 The Beachbody Company, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 shares in Q4 2023, an estimated $213.
- Raymond James & Associates first reported a position in The Beachbody Company, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 in Q2 2021 and held it in 10 quarters.
- Raymond James & Associates's The Beachbody Company, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position peaked at $94K in Q2 2021.
- 2 funds tracked by Wall St. Rank held The Beachbody Company, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 as of Q4 2023.
Based on Raymond James & Associates's 13F filing for Q4 2023, filed 16 Jan 2024.